FDA — authorised 26 November 1948
- Status: approved
🇺🇸 Migergot in United States
FDA authorised Migergot on 26 November 1948
Marketing authorisations
FDA — authorised 4 October 1983
- Application: ANDA086557
- Marketing authorisation holder: COSETTE
- Local brand name: MIGERGOT
- Indication: SUPPOSITORY — RECTAL
- Status: approved
FDA — authorised 9 June 1987
- Application: ANDA087693
- Marketing authorisation holder: PANGEA
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 16 September 2005
- Application: ANDA040590
- Marketing authorisation holder: MIKART
- Status: approved
Migergot in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Migergot approved in United States?
Yes. FDA authorised it on 26 November 1948; FDA authorised it on 4 October 1983; FDA authorised it on 9 June 1987.
Who is the marketing authorisation holder for Migergot in United States?
Marketing authorisation holder not available in our data.